Today we begin a several-part series on Alzheimer’s disease, the most common cause of memory loss and dementia. Alzheimer’s is a brain disease characterized by amyloid plaques and neurofibrillary ...

Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious stages of ...

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a ...

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression ...

The progression of Alzheimer's disease is poorly understood, but new research may have found how the plaques that cause it ...

Walking a few thousand steps daily may help hold off Alzheimer’s for years, a Mass General Brigham study found. Even moderate ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

A rock legend who is in the late stages of Alzheimer's disease is being honored with a documentary film that debuts June 6 at the IFC Center in New York City. "Hubris, anger, prejudice…doo-wop, reggae ...

Lithium deficiency in the brain could be a cause of Alzheimer's disease—and a new potential target for treatment. Ten years in the making, this is the finding of researchers at Harvard Medical School ...

The European Commission has for the first time approved an Alzheimer's therapy that targets the underlying disease processes. Lecanemab, an antibody, is for early-stage treatment and is the first drug ...

Please provide your email address to receive an email when new articles are posted on . Earlier initiation of donanemab reduced the risk of disease progression on the Clinical Dementia Rating-Global ...

"Lifestyle changes may slow the emergence of cognitive symptoms if we act early.” said neurologist Dr. Jasmeer Chhatwal.